Alphatherapy, the new impetus to targeted radionuclide therapy?
Eur J Nucl Med Mol Imaging
.
2018 Jul;45(8):1362-1363.
doi: 10.1007/s00259-018-4026-z.
Authors
Jean-François Chatal
1
,
Françoise Kraeber-Bodéré
2
,
Michel Chérel
3
2
,
Ferid Haddad
3
Affiliations
1
Groupement d'Intérêt Public Arronax and University of Nantes, Nantes, France. jean-francois.chatal@univ-nantes.fr.
2
ICO-CHU Nantes-UN-CRCINA, Nantes, France.
3
Groupement d'Intérêt Public Arronax and University of Nantes, Nantes, France.
PMID:
29696441
DOI:
10.1007/s00259-018-4026-z
No abstract available
Publication types
Editorial
Comment
MeSH terms
Neoplasms
Radioimmunotherapy*
Radioisotopes*
Substances
Radioisotopes